These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 24905637)

  • 1. Linkage of a de-identified United States rheumatoid arthritis registry with administrative data to facilitate comparative effectiveness research.
    Curtis JR; Chen L; Bharat A; Delzell E; Greenberg JD; Harrold L; Kremer J; Setoguchi S; Solomon DH; Xie F; Yun H
    Arthritis Care Res (Hoboken); 2014 Dec; 66(12):1790-8. PubMed ID: 24905637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of health plan combined with registry data to predict clinical trial recruitment.
    Curtis JR; Wright NC; Xie F; Chen L; Zhang J; Saag KG; Bharat A; Kremer J; Cofield S; Winthrop K; Delzell E
    Clin Trials; 2014 Feb; 11(1):96-101. PubMed ID: 24346611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methodological Challenges When Comparing Demographic and Clinical Characteristics of International Observational Registries.
    Verstappen SM; Askling J; Berglind N; Franzen S; Frisell T; Garwood C; Greenberg JD; Holmqvist M; Horne L; Lampl K; Michaud K; Nyberg F; Pappas DA; Reed G; Symmons DP; Tanaka E; Tran TN; Yamanaka H; Ho M
    Arthritis Care Res (Hoboken); 2015 Dec; 67(12):1637-45. PubMed ID: 26201948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can rheumatoid arthritis (RA) registries provide contextual safety data for modern RA clinical trials? The case for mortality and cardiovascular disease.
    Michaud K; Berglind N; Franzén S; Frisell T; Garwood C; Greenberg JD; Ho M; Holmqvist M; Horne L; Inoue E; Nyberg F; Pappas DA; Reed G; Symmons D; Tanaka E; Tran TN; Verstappen SM; Wesby-van Swaay E; Yamanaka H; Askling J
    Ann Rheum Dis; 2016 Oct; 75(10):1797-805. PubMed ID: 26857699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Design characteristics of the CORRONA CERTAIN study: a comparative effectiveness study of biologic agents for rheumatoid arthritis patients".
    Pappas DA; Kremer JM; Reed G; Greenberg JD; Curtis JR
    BMC Musculoskelet Disord; 2014 Apr; 15():113. PubMed ID: 24690143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Agreement of Medication Information Derived From EHR Data Compared to Medicare Insurance Claims: An Analysis of Biologic Disease-Modifying Antirheumatic Drugs.
    Li J; Baker R; Stovall R; Curtis JR; Xie F; Yazdany J; Schmajuk G
    Pharmacoepidemiol Drug Saf; 2024 Oct; 33(10):e70020. PubMed ID: 39375936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease activity and patient-reported outcomes in patients with rheumatoid arthritis and Sjögren's syndrome enrolled in a large observational US registry.
    Harrold LR; Shan Y; Rebello S; Kramer N; Connolly SE; Alemao E; Kelly S; Kremer JM; Rosenstein ED
    Rheumatol Int; 2020 Aug; 40(8):1239-1248. PubMed ID: 32449040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and Predictors of Biological Antirheumatic Drug Discontinuation Attempts among Patients with Rheumatoid Arthritis in Remission: A CORRONA and NinJa Collaborative Cohort Study.
    Yoshida K; Radner H; Mjaavatten MD; Greenberg JD; Kavanaugh A; Kishimoto M; Matsui K; Okada M; Reed G; Saeki Y; Tohma S; Kremer J; Solomon DH
    J Rheumatol; 2015 Dec; 42(12):2238-46. PubMed ID: 26523025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effectiveness and safety of rituximab versus subsequent anti-tumor necrosis factor therapy in patients with rheumatoid arthritis with prior exposure to anti-tumor necrosis factor therapies in the United States Corrona registry.
    Harrold LR; Reed GW; Magner R; Shewade A; John A; Greenberg JD; Kremer JM
    Arthritis Res Ther; 2015 Sep; 17(1):256. PubMed ID: 26382589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of an indirect linkage algorithm to combine registry data with Medicare claims.
    Mao J; Moore KO; Columbo JA; Mehta KS; Goodney PP; Sedrakyan A
    J Vasc Surg; 2022 Jul; 76(1):266-271.e2. PubMed ID: 35181518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Treatment With Biologic Agents on the Use of Mechanical Devices Among Rheumatoid Arthritis Patients in a Large US Patient Registry.
    Strand V; Greenberg JD; Griffith J; Bao Y; Saunders KC; Garg V; Li G; Ganguli A
    Arthritis Care Res (Hoboken); 2016 Jul; 68(7):914-21. PubMed ID: 26555655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using epidemiological registry data to provide background rates as context for adverse events in a rheumatoid arthritis drug development program: a coordinated approach.
    Nyberg F; Askling J; Berglind N; Franzén S; Ho M; Holmqvist M; Horne L; Lampl K; Michaud K; Pappas DA; Reed G; Symmons D; Tanaka E; Tran TN; Verstappen SM; Wesby-van Swaay E; Yamanaka H; Greenberg JD
    Pharmacoepidemiol Drug Saf; 2015 Nov; 24(11):1121-32. PubMed ID: 26303866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linking a Total Ankle Arthroplasty Registry to Medicare Inpatient Claims without Unique Identifiers.
    Raman SR; Hammill BG; Queen RM; Adams SB; Curtis LH
    J Bone Joint Surg Am; 2018 Jun; 100(12):1016-1022. PubMed ID: 29916928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Corrona US registry of rheumatic and autoimmune diseases.
    Kremer JM
    Clin Exp Rheumatol; 2016; 34(5 Suppl 101):S96-S99. PubMed ID: 27762197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design characteristics of the Corrona Japan rheumatoid arthritis registry.
    Yamanaka H; Kishimoto M; Pappas DA; Greenberg JD; Kremer JM; Tanaka Y
    Mod Rheumatol; 2018 Jan; 28(1):95-100. PubMed ID: 28448195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do Patients With Moderate or High Disease Activity Escalate Rheumatoid Arthritis Therapy According to Treat-to-Target Principles? Results From the Rheumatology Informatics System for Effectiveness Registry of the American College of Rheumatology.
    Yun H; Chen L; Xie F; Patel H; Boytsov N; Zhang X; Curtis JR
    Arthritis Care Res (Hoboken); 2020 Feb; 72(2):166-175. PubMed ID: 31566905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The CORRONA database.
    Kremer JM
    Clin Exp Rheumatol; 2005; 23(5 Suppl 39):S172-7. PubMed ID: 16273803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Derivation and preliminary validation of an administrative claims-based algorithm for the effectiveness of medications for rheumatoid arthritis.
    Curtis JR; Baddley JW; Yang S; Patkar N; Chen L; Delzell E; Mikuls TR; Saag KG; Singh J; Safford M; Cannon GW
    Arthritis Res Ther; 2011; 13(5):R155. PubMed ID: 21933396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The comparative effectiveness of biologics among older adults and disabled rheumatoid arthritis patients in the Medicare population.
    Yun H; Xie F; Delzell E; Chen L; Yang S; Saag KG; Joseph G; Harrison D; Curtis JR
    Br J Clin Pharmacol; 2015 Dec; 80(6):1447-57. PubMed ID: 26130274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validity of deterministic record linkage using multiple indirect personal identifiers: linking a large registry to claims data.
    Setoguchi S; Zhu Y; Jalbert JJ; Williams LA; Chen CY
    Circ Cardiovasc Qual Outcomes; 2014 May; 7(3):475-80. PubMed ID: 24755909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.